Today: 11 December 2025
Subscribe
Browse Tag

investor update

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025

Telomir Pharmaceuticals (NASDAQ: TELO) shares react to new preclinical leukemia data and a director resignation on November 21, 2025. Here’s what today’s Telomir-1 news means for TELO stock and investors. What happened to Telomir Pharmaceuticals (TELO) today? On Friday, November
21 November 2025
 ·  ·  ·  ·  · 
Opendoor (OPEN) today — Nov. 10, 2025: JPMorgan calls a ‘major transformation,’ while investors weigh a $1.2B note repurchase, 180.6M‑share sale, and a new tradable‑warrants dividend

Opendoor (OPEN) Pops as CEO Pledges $1M Share Purchase and Goldman Discloses 5.1% Stake — What Investors Need to Know Today (Nov. 11, 2025)

Date: November 11, 2025 Ticker: NASDAQ: OPEN At a Glance (Nov. 11) OPEN Stock Today: Price, Volume and Context By late session Tuesday, Opendoor traded near $8.48, up about 0.53 on the day, after ranging from $7.82 to $8.61. Turnover was intense, topping 224 million shares, underscoring how retail flows
11 November 2025
 ·  ·  ·  ·  · 
Go toTop